Quantitative Brain Positron Emission Tomography in Female 5XFAD Alzheimer Mice: Pathological Features and Sex-Specific Alterations
Successful back-translating clinical biomarkers and molecular imaging methods of Alzheimer's disease (AD), including positron emission tomography (PET), are very valuable for the evaluation of new therapeutic strategies and increase the quality of preclinical studies. 18F-Fluorodeoxyglucose (FD...
Guardado en:
Autores principales: | Caroline Bouter, Caroline Irwin, Timon N. Franke, Nicola Beindorff, Yvonne Bouter |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/55813cdb89144d8a9fe5d94d8bb4ad80 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
18F-THK5351 Positron Emission Tomography Imaging in Neurodegenerative Tauopathies
por: Michinori Ezura, et al.
Publicado: (2021) -
USO DE LA TOMOGRAFIA DE EMISION DE POSITRONES EN EL CANCER COLORRECTAL
por: González E,Patricio, et al.
Publicado: (2002) -
Evaluation of Age and Sex-Related Metabolic Changes in Healthy Subjects: An Italian Brain 18F-FDG PET Study
por: Michela Allocca, et al.
Publicado: (2021) -
Uso de la tomografía de emisión de positrones PET con F18-FDG en la evaluación de lesiones pulmonares sospechosas de neoplasia
por: Jofré M,M Josefina, et al.
Publicado: (2005) -
Sweetening Pharmaceutical Radiochemistry by <sup>18</sup>F-Fluoroglycosylation: Recent Progress and Future Prospects
por: Sandip S. Shinde, et al.
Publicado: (2021)